Braveheart Bio Prices Upsized Initial Public Offering on Nasdaq at $18 per Share

MT Newswires Live

08/06

Braveheart Bio (BRVE) priced its upsized initial public offering of approximately 21.3 million shares at $18 per share, the company said late Wednesday.

All shares in the offering are being sold by Braveheart Bio.

The shares are expected to start trading on the Nasdaq Global Market on Thursday under the ticker symbol BRVE. Braveheart Bio said the offering is expected to close on Friday.

The company said it also granted the underwriters a 30-day option to purchase up to an additional 3.2 million shares at the IPO price.

Braveheart Bio expects to generate approximately $382.5 million in gross proceeds from the offering.

Goldman Sachs, Jefferies, TD Cowen, Stifel, and Cantor are acting as joint book-running managers.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2657681246"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2657681246\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2657681246?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657681246","market":"hk","top_or_hot":-1,"title":"Braveheart Bio Prices Upsized Initial Public Offering on Nasdaq at $18 per Share","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/BRVE\">Braveheart Bio</a> (BRVE) priced its upsized initial public offering of approximately 21.3 million shares at $18 per share, the company said late Wednesday.</p><p>All shares in the offering are being sold by Braveheart Bio.</p><p>The shares are expected to start trading on the Nasdaq Global Market on Thursday under the ticker symbol BRVE. Braveheart Bio said the offering is expected to close on Friday.</p><p>The company said it also granted the underwriters a 30-day option to purchase up to an additional 3.2 million shares at the IPO price.</p><p>Braveheart Bio expects to generate approximately $382.5 million in gross proceeds from the offering.</p><p>Goldman Sachs, Jefferies, TD Cowen, <a href=\"https://laohu8.com/S/SFB\">Stifel</a>, and Cantor are acting as joint book-running managers.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Braveheart Bio Prices Upsized Initial Public Offering on Nasdaq at $18 per Share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBraveheart Bio Prices Upsized Initial Public Offering on Nasdaq at $18 per Share\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-08-06 17:42</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/BRVE\">Braveheart Bio</a> (BRVE) priced its upsized initial public offering of approximately 21.3 million shares at $18 per share, the company said late Wednesday.</p><p>All shares in the offering are being sold by Braveheart Bio.</p><p>The shares are expected to start trading on the Nasdaq Global Market on Thursday under the ticker symbol BRVE. Braveheart Bio said the offering is expected to close on Friday.</p><p>The company said it also granted the underwriters a 30-day option to purchase up to an additional 3.2 million shares at the IPO price.</p><p>Braveheart Bio expects to generate approximately $382.5 million in gross proceeds from the offering.</p><p>Goldman Sachs, Jefferies, TD Cowen, <a href=\"https://laohu8.com/S/SFB\">Stifel</a>, and Cantor are acting as joint book-running managers.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IPOS","symbol_name":"Renaissance International IPO ETF","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2657681246","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2657681246","pubTimestamp":1786009378,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Braveheart Bio  priced its upsized initial public offering of approximately 21.3 million shares at $18 per share, the company said late Wednesday.All shares in the offering are being sold by Braveheart Bio.The shares are expected to start trading on the Nasdaq Global Market on Thursday under the ticker symbol BRVE. Braveheart Bio said the offering is expected to close on Friday.The company said it also granted the underwriters a 30-day option to purchase up to an additional 3.2 million shares at the IPO price.Braveheart Bio expects to generate approximately $382.5 million in gross proceeds from the offering.Goldman Sachs, Jefferies, TD Cowen, Stifel, and Cantor are acting as joint book-running managers.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IPOS":"Renaissance International IPO ETF","BRVE":"Braveheart Bio","LCLG":"Logan Capital Broad Innovative Growth ETF"},"translate_title":"Braveheart Bio 将纳斯达克首次公开募股价格提高至每股 18 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NQmain":1.5,"BRVE":1.5,"IPOS":1.5,"LCLG":1.5},"content_text":"Braveheart Bio (BRVE) priced its upsized initial public offering of approximately 21.3 million shares at $18 per share, the company said late Wednesday.All shares in the offering are being sold by Braveheart Bio.The shares are expected to start trading on the Nasdaq Global Market on Thursday under the ticker symbol BRVE. Braveheart Bio said the offering is expected to close on Friday.The company said it also granted the underwriters a 30-day option to purchase up to an additional 3.2 million shares at the IPO price.Braveheart Bio expects to generate approximately $382.5 million in gross proceeds from the offering.Goldman Sachs, Jefferies, TD Cowen, Stifel, and Cantor are acting as joint book-running managers.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}